Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Development of a highly sensitive in vitro endothelial cell toxicity assay for evaluating ricin toxin A chain-based vaccines or therapeutics.

Machesky NJ, Rusnak JM, Moore EH, Dorsey CB, Ward LA.

Toxicon. 2019 Jun 14. pii: S0041-0101(19)30190-4. doi: 10.1016/j.toxicon.2019.06.015. [Epub ahead of print]

PMID:
31207351
2.

Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.

Rusnak JM, Dupuy LC, Niemuth NA, Glenn AM, Ward LA.

Comp Med. 2018 Oct 1;68(5):380-395. doi: 10.30802/AALAS-CM-18-000027. Epub 2018 Oct 3.

3.

Blood pressure-lowering effect of the sodium glucose co-transporter-2 inhibitor ertugliflozin, assessed via ambulatory blood pressure monitoring in patients with type 2 diabetes and hypertension.

Amin NB, Wang X, Mitchell JR, Lee DS, Nucci G, Rusnak JM.

Diabetes Obes Metab. 2015 Aug;17(8):805-8. doi: 10.1111/dom.12486. Epub 2015 Jun 17.

PMID:
25951755
4.

Dose-ranging efficacy and safety study of ertugliflozin, a sodium-glucose co-transporter 2 inhibitor, in patients with type 2 diabetes on a background of metformin.

Amin NB, Wang X, Jain SM, Lee DS, Nucci G, Rusnak JM.

Diabetes Obes Metab. 2015 Jun;17(6):591-8. doi: 10.1111/dom.12460. Epub 2015 Mar 31.

PMID:
25754396
5.

Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009.

Conger NG, Paolino KM, Osborn EC, Rusnak JM, G√ľnther S, Pool J, Rollin PE, Allan PF, Schmidt-Chanasit J, Rieger T, Kortepeter MG.

Emerg Infect Dis. 2015 Jan;21(1):23-31. doi: 10.3201/eid2101.141413.

6.

Genetic association analyses of nitric oxide synthase genes and neural tube defects vary by phenotype.

Soldano KL, Garrett ME, Cope HL, Rusnak JM, Ellis NJ, Dunlap KL, Speer MC, Gregory SG, Ashley-Koch AE.

Birth Defects Res B Dev Reprod Toxicol. 2013 Oct;98(5):365-73. doi: 10.1002/bdrb.21079. Epub 2013 Dec 9.

7.

Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.

Rusnak JM, Gibbs P, Boudreau E, Clizbe DP, Pittman P.

Vaccine. 2011 Apr 12;29(17):3222-9. doi: 10.1016/j.vaccine.2011.02.037. Epub 2011 Feb 26.

PMID:
21354483
8.

Botulinum neurotoxin vaccines: Past history and recent developments.

Rusnak JM, Smith LA.

Hum Vaccin. 2009 Dec;5(12):794-805. Epub 2009 Dec 1. Review.

PMID:
19684478
9.

Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea.

Rusnak JM, Byrne WR, Chung KN, Gibbs PH, Kim TT, Boudreau EF, Cosgriff T, Pittman P, Kim KY, Erlichman MS, Rezvani DF, Huggins JW.

Antiviral Res. 2009 Jan;81(1):68-76. doi: 10.1016/j.antiviral.2008.09.007. Epub 2008 Oct 31. Erratum in: Antiviral Res. 2009 Jul;83(1):99-100.

PMID:
18977392
10.

Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit.

Kortepeter MG, Martin JW, Rusnak JM, Cieslak TJ, Warfield KL, Anderson EL, Ranadive MV.

Emerg Infect Dis. 2008 Jun;14(6):881-7. doi: 10.3201/eid1406.071489.

11.

Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.

Dembek ZF, Smith LA, Rusnak JM.

Disaster Med Public Health Prep. 2007 Nov;1(2):122-34. doi: 10.1097/DMP.0b013e318158c5fd. Review.

PMID:
18388640
12.

Botulinum neurotoxin vaccines: past, present, and future.

Smith LA, Rusnak JM.

Crit Rev Immunol. 2007;27(4):303-18. Review.

PMID:
18197811
13.

Reaction after smallpox vaccination.

Aldis JW, Kortepeter MG, Rusnak JM.

Am Fam Physician. 2006 Jul 1;74(1):145-7. No abstract available.

14.

History of U.S. military contributions to the study of parasitic diseases.

Crum NF, Aronson NE, Lederman ER, Rusnak JM, Cross JH.

Mil Med. 2005 Apr;170(4 Suppl):17-29. Review.

PMID:
15916280
15.

Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers.

Rusnak JM, Kortepeter MG, Hawley RJ, Anderson AO, Boudreau E, Eitzen E.

Biosecur Bioterror. 2004;2(4):281-93.

PMID:
15650438
16.

Laboratory exposures to staphylococcal enterotoxin B.

Rusnak JM, Kortepeter M, Ulrich R, Poli M, Boudreau E.

Emerg Infect Dis. 2004 Sep;10(9):1544-9. Review.

18.

Management guidelines for laboratory exposures to agents of bioterrorism.

Rusnak JM, Kortepeter MG, Hawley RJ, Boudreau E, Aldis J, Pittman PR.

J Occup Environ Med. 2004 Aug;46(8):791-800.

PMID:
15300131
19.

An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study).

Rusnak JM, Kopecky SL, Clements IP, Gibbons RJ, Holland AE, Peterman HS, Martin JS, Saoud JB, Feldman RL, Breisblatt WM, Simons M, Gessler CJ Jr, Yu AS.

Am J Cardiol. 2001 Sep 1;88(5):482-7.

PMID:
11524054
20.

Pharmacogenomics: a clinician's primer on emerging technologies for improved patient care.

Rusnak JM, Kisabeth RM, Herbert DP, McNeil DM.

Mayo Clin Proc. 2001 Mar;76(3):299-309. Review.

PMID:
11243277
21.

A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.

Rice RL, Rusnak JM, Yokokawa F, Yokokawa S, Messner DJ, Boynton AL, Wipf P, Lazo JS.

Biochemistry. 1997 Dec 16;36(50):15965-74.

PMID:
9398331
22.

Clinical significance of discordant CD4 count and CD4 percentage in HIV-infected individuals.

Le TP, Tribble DR, Zhou SY, Malone L, Chung RC, Rusnak JM, Wagner KF.

AIDS. 1997 Sep;11(11):1395-6. No abstract available.

PMID:
9302451
23.

Enhanced apoptosis in metallothionein null cells.

Kondo Y, Rusnak JM, Hoyt DG, Settineri CE, Pitt BR, Lazo JS.

Mol Pharmacol. 1997 Aug;52(2):195-201.

PMID:
9271341
24.

The heat-shock response attenuates lipopolysaccharide-mediated apoptosis in cultured sheep pulmonary artery endothelial cells.

Wong HR, Mannix RJ, Rusnak JM, Boota A, Zar H, Watkins SC, Lazo JS, Pitt BR.

Am J Respir Cell Mol Biol. 1996 Dec;15(6):745-51.

PMID:
8969269
25.

Synthesis of chemoreversible prodrugs of ara-C with variable time-release profiles. Biological evaluation of their apoptotic activity.

Wipf P, Li W, Adeyeye CM, Rusnak JM, Lazo JS.

Bioorg Med Chem. 1996 Oct;4(10):1585-96.

PMID:
8931928
26.

Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells.

Hoyt DG, Rusnak JM, Mannix RJ, Modzelewski RA, Johnson CS, Lazo JS.

Cancer Res. 1996 Sep 15;56(18):4146-9.

27.
28.

Genesis of discrete higher order DNA fragments in apoptotic human prostatic carcinoma cells.

Rusnak JM, Calmels TP, Hoyt DG, Kondo Y, Yalowich JC, Lazo JS.

Mol Pharmacol. 1996 Feb;49(2):244-52.

PMID:
8632756
29.

Collagen is a survival factor against LPS-induced apoptosis in cultured sheep pulmonary artery endothelial cells.

Hoyt DG, Mannix RJ, Rusnak JM, Pitt BR, Lazo JS.

Am J Physiol. 1995 Aug;269(2 Pt 1):L171-7.

PMID:
7653577
30.

Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons.

Blatt SP, McCarthy WF, Bucko-Krasnicka B, Melcher GP, Boswell RN, Dolan J, Freeman TM, Rusnak JM, Hensley RE, Ward WW, et al.

J Infect Dis. 1995 Apr;171(4):837-44.

PMID:
7535828
31.

Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.

Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S, Yalowich JC.

Mol Pharmacol. 1994 Oct;46(4):605-11.

PMID:
7969039
33.

Clinical gnathostomiasis: case report and review of the English-language literature.

Rusnak JM, Lucey DR.

Clin Infect Dis. 1993 Jan;16(1):33-50. Review.

PMID:
8448317
34.

Toxicity of bilirubin to Leishmania tropica promastigotes.

Simon MW, Rusnak JM, Mukkada AJ.

Exp Parasitol. 1976 Feb;39(1):51-8. No abstract available.

PMID:
1253883

Supplemental Content

Loading ...
Support Center